In one small study BCL2A1 mRNA was over-expressed in acute lymphoid leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL), chronic myeloid leukemia (CML), and mantle cell lymphoma tumor cells compared to normal marrow cells [23]. This evidence concerns the gene BCL2A1 and acute myeloid leukemia.